Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 17;13(3):413-420.
doi: 10.1093/ckj/sfz068. eCollection 2020 Jun.

Effects of early high-dose erythropoietin on acute kidney injury following cardiac arrest: exploratory post hoc analyses from an open-label randomized trial

Affiliations

Effects of early high-dose erythropoietin on acute kidney injury following cardiac arrest: exploratory post hoc analyses from an open-label randomized trial

Lucie Guillemet et al. Clin Kidney J. .

Abstract

Background: Acute kidney injury (AKI) is frequent in patients resuscitated from cardiac arrest (CA) and may worsen outcome. Experimental data suggest a renoprotective effect by treating these patients with a high dose of erythropoietin (Epo) analogues. We aimed to evaluate the efficacy of epoetin alpha treatment on renal outcome after CA.

Methods: We did a post hoc analysis of the Epo-ACR-02 trial, which randomized patients with a persistent coma after a witnessed out-of-hospital CA. Only patients admitted in one intensive care unit were analysed. In the intervention group, patients received five intravenous injections of Epo spaced 12 h apart during the first 48 h, started as soon as possible after resuscitation. In the control group, patients received standard care without Epo. The main endpoint was the proportion of patients with persistent AKI defined by Kidney Disease: Improving Global Outcomes criteria at Day 2. Secondary endpoints included the occurrence of AKI through Day 7, estimated glomerular filtration rate (eGFR) at Day 28, haematological indices and adverse events.

Results: A total of 162 patients were included in the primary analysis (74 in the Epo group, 88 in the control group). Baseline characteristics were similar in the two groups. At Day 2, 52.8% of the patients (38/72) in the intervention group had an AKI, as compared with 54.4% of the patients (46/83) in the control group (P = 0.74). There was no significant difference between the two groups regarding the proportion of patients with AKI through Day 7. Among patients with persistent AKI at Day 2, 33% (4/12) in the intervention group had an eGFR <75 mL/min/1.73 m2 compared with 25% (3/12) in the control group at Day 28 (P = 0.99). We found no significant differences in haematological indices or adverse events.

Conclusion: After CA, early administration of Epo did not confer any renal protective effect as compared with standard therapy.

Keywords: cardiopulmonary resuscitation; renal function; reperfusion injury.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Flow chart.

References

    1. Neumar RW, Nolan JP, Adrie C. et al. Post cardiac arrest syndrome: epidemiology, pathophysiology, treatment and prognostication. A consensus statement from the international liaison committee on resuscitation. Circulation 2008; 118: 2452–2483 - PubMed
    1. Bonventre JV, Yang L.. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 2011; 121: 4210–4221 - PMC - PubMed
    1. Geri G, Guillemet L, Dumas F. et al. Acute kidney injury after out-of-hospital cardiac arrest: risk factors and prognosis in a large cohort. Intensive Care Med 2015; 41: 1273–1280 - PubMed
    1. Yanta J, Guyette FX, Doshi AA. et al. Renal dysfunction is common following resuscitation from out-of-hospital cardiac arrest. Resuscitation 2013; 84: 1371–1374 - PubMed
    1. Tujjar O, Mineo G, Dell'Anna A. et al. Acute kidney injury after cardiac arrest. Crit Care 2015; 19: 169. - PMC - PubMed